295 related articles for article (PubMed ID: 31657895)
1. DARK Classics in Chemical Neuroscience: NBOMes.
Poulie CBM; Jensen AA; Halberstadt AL; Kristensen JL
ACS Chem Neurosci; 2020 Dec; 11(23):3860-3869. PubMed ID: 31657895
[No Abstract] [Full Text] [Related]
2. NBOMes-Highly Potent and Toxic Alternatives of LSD.
Zawilska JB; Kacela M; Adamowicz P
Front Neurosci; 2020; 14():78. PubMed ID: 32174803
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT
Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Johnson RA; Janowsky A
Biochem Pharmacol; 2018 Dec; 158():27-34. PubMed ID: 30261175
[TBL] [Abstract][Full Text] [Related]
4. Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of
Jensen AA; McCorvy JD; Leth-Petersen S; Bundgaard C; Liebscher G; Kenakin TP; Bräuner-Osborne H; Kehler J; Kristensen JL
J Pharmacol Exp Ther; 2017 Jun; 361(3):441-453. PubMed ID: 28360333
[TBL] [Abstract][Full Text] [Related]
5. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
[TBL] [Abstract][Full Text] [Related]
6. Effects of the 5-HT
Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J
Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648
[TBL] [Abstract][Full Text] [Related]
7. Molecular and Medical Aspects of Psychedelics.
Wojtas A; Gołembiowska K
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203411
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
Halberstadt AL
Curr Top Behav Neurosci; 2017; 32():283-311. PubMed ID: 28097528
[TBL] [Abstract][Full Text] [Related]
9. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
Kamińska K; Świt P; Malek K
J Anal Toxicol; 2021 Jan; 44(9):947-956. PubMed ID: 32128596
[TBL] [Abstract][Full Text] [Related]
10. Mescaline: The forgotten psychedelic.
Vamvakopoulou IA; Narine KAD; Campbell I; Dyck JRB; Nutt DJ
Neuropharmacology; 2023 Jan; 222():109294. PubMed ID: 36252614
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
[TBL] [Abstract][Full Text] [Related]
12. Hallucinogens and Serotonin 5-HT
López-Giménez JF; González-Maeso J
Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
[TBL] [Abstract][Full Text] [Related]
13. Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).
Nichols DE
ACS Chem Neurosci; 2018 Oct; 9(10):2331-2343. PubMed ID: 29461039
[TBL] [Abstract][Full Text] [Related]
14. 25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor.
Märcher Rørsted E; Jensen AA; Kristensen JL
ChemMedChem; 2021 Nov; 16(21):3263-3270. PubMed ID: 34288515
[TBL] [Abstract][Full Text] [Related]
15. Introducing Conformational Restraints on 25CN-NBOH: A Selective 5-HT
Marcher-Rørsted E; Nykodemová J; Harpsøe K; Jensen AA; Kristensen JL
ACS Med Chem Lett; 2023 Mar; 14(3):319-325. PubMed ID: 36923922
[TBL] [Abstract][Full Text] [Related]
16. Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT
Poulie CBM; Pottie E; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Stove CP; Kristensen JL
J Med Chem; 2022 Sep; 65(18):12031-12043. PubMed ID: 36099411
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Fate of Hallucinogenic NBOMes.
Leth-Petersen S; Gabel-Jensen C; Gillings N; Lehel S; Hansen HD; Knudsen GM; Kristensen JL
Chem Res Toxicol; 2016 Jan; 29(1):96-100. PubMed ID: 26669514
[TBL] [Abstract][Full Text] [Related]
18. Off-target activity of NBOMes and NBOMe analogs at the µ opioid receptor.
Deventer MH; Persson M; Laus A; Pottie E; Cannaert A; Tocco G; Gréen H; Stove CP
Arch Toxicol; 2023 May; 97(5):1367-1384. PubMed ID: 36853332
[TBL] [Abstract][Full Text] [Related]
19. The selective 5-HT
Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, systemic toxicity, thermoregulation and acute behavioural effects of 25CN-NBOMe.
Šíchová K; Syrová K; Kofroňová E; Pinterova-Leca N; Vejmola Č; Nykodemová J; Palivec P; Olejníková L; Danda H; Jorratt P; Adam Š; Hiep BQ; Štefková-Mazochová K; Končická M; Kuchař M; Páleníček T
Addict Biol; 2022 Sep; 27(5):e13216. PubMed ID: 36001433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
